Trends in Opioid Use Disorder Medication Among Medicaid Beneficiaries

Recent research indicates a decrease in opioid use disorder diagnoses among Medicaid beneficiaries while medication access has significantly increased.
New SAMHSA Guidelines on Harm Reduction Funding

SAMHSA has revised its guidance on funding for harm reduction services, detailing eligible supplies and services while distancing from illicit drug use.
Medicaid Revalidation: New Federal Demands for Providers

Federal demands for Medicaid revalidation in Vermont highlight the ongoing battle against fraud in healthcare services.
NC Tackles Rising ABA Therapy Costs Amid Fraud Allegations

As North Carolina sees skyrocketing costs in ABA therapy, concerns arise over potential fraud and the need for stricter regulations.
Rogers Behavioral Health Workers Secure Union Representation

Over 93% of workers at Rogers Behavioral Health in Wisconsin voted for unionization, highlighting growing trends in the sector.
FDA Backs Studies on Psychedelic Drugs for Mental Illness

The FDA’s recent actions support ongoing studies into psychedelic drugs as potential treatments for serious mental illnesses.
Mississippi Center Reports a 35% Rise in Alcohol Admissions

The Oxford Treatment Center reports a notable rise in patients seeking help for alcohol use, reflective of broader trends in public health.
Improving Patient Attendance with Just In Time Scheduling

Comprehensive Healthcare’s new scheduling model boosts appointment show rates dramatically, helping to address urgent care needs.
Hopebridge’s Impact on ABA Services at CASP 2026

Hopebridge showcases their leadership in ABA services through multiple sessions at CASP 2026, addressing key challenges in the industry.
Understanding Psilocybin: Trump’s Initiative for Mental Health Treatments

This article delves into psilocybin research and the U.S. government’s support for psychedelic treatment in mental health.